Intestinal microbiota in children and adolescents with eating disorders — a psychoneuroimmunology perspective
Official title: Getting Into the Guts of Eating Disorders in Children and Adolescents. A Perspective From Psychoneuroimmunology.
Run by Spanish National Research Council · NCT07066033 · Data updated 2026-11-12
This project will test whether the mix and activity of gut bacteria differ in children and adolescents with eating disorders and whether those differences relate to diet, symptoms, or one-year treatment outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years to 18 Years |
| Sex | All |
| Enrollment | 158 (estimated) |
| Sponsor | Spanish National Research Council Government |
| Locations | 2 sites (Madrid, Madrid and 1 other locations) |
| Status | Recruiting |
| Started | August 29, 2024 |
| Main results expected | December 2026 |
| Study ends | August 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07066033 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and adolescents aged 7.0–17.9 years with a DSM‑5 diagnosis of anorexia nervosa (restrictive or binge–purge), OSFED, or ARFID with first episode or symptom duration under one year and parental/adolescent consent.
✕Probably not a fit
Patients with long-standing or previously unsuccessfully treated eating disorders, current infections, certain endocrine or gastrointestinal diseases, severe neurodevelopmental disorders, or recent suicidal behavior are excluded and unlikely to benefit from the study results.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational cohort study enrolling patients aged 7 to 17.9 years with a recent-onset eating disorder to compare their intestinal microbiota composition and function with healthy peers. Researchers collect stool samples, dietary and lifestyle histories, and standardized measures of psychopathology and neuroendocrine markers at baseline, then follow clinical course to one year to see if baseline factors predict outcome. The study also compares microbiota signatures across eating disorder subtypes (AN restrictive, AN binge–purge, OSFED, ARFID). Laboratory work is done in collaboration with a national food science institute and a pediatric university hospital in Madrid.
Why it matters
Potential benefit: If successful, the study could identify gut microbiota patterns linked to symptoms or prognosis that help target future personalized interventions or guide diet-based support.
How similar studies have gone: Prior adult and some pediatric studies have reported microbiota differences in eating disorders but findings have been inconsistent and remain largely exploratory, so this approach is promising but not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 7-17.9 years * Diagnosis of Anorexia Nervosa, both restrictive (ANR) and binge-purging (ANBP) subtypes, Other Specified Feeding and Eating Disorders (OSFED), Avoidant/Restrictive Food Intake Disorder (ARFID) according to DSM-V (APA, 2013). * Males and females * First episode or less than 1 year evolution since initial symptoms * Written informed consent by parent/tutor and also by the adolescent if age is more than 12 y. Exclusion Criteria: * Comorbidities: Current infectious disease at admission; Severe neurodevelopmental disorders with impaired language development; Moderate or severe intellectual disability; Endocrine disorders such as diabetes mellitus or thyroid disease; Celiac disease; Suicidal behaviors in the previous 3 months. * Patients with previous unsuccessful treatments for more than one year. * Use of the following medications before entering the study: laxatives, anabolic steroids, immunosuppressant drugs, Helicobacter pylori eradication treatment, thyroid hormones or antibiotic treatment in the previous two months * Surgery in the previous month. Control group participants' exclusion criteria are the same plus the following: History with diagnosis of mental disease (including EDs). Current autoimmune or infectious disease.
Where it's running
-
Hospital Infantil Universitario Niño Jesús
Madrid, Madrid, Spain Recruiting -
Institute of Food Science and Technology and Nutrition (ICTAN, CSIC)
Madrid, Madrid, Spain Recruiting
Study contacts
- Principal investigator: Mar Faya, PhD, MD — Hospital Infantil Universitario Niño Jesús
- Study coordinator: Esther Nova, PhD
- Email: enova@ictan.csic.es
- Phone: 34 5492300
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Young Athlete Body Project for Adolescent Athletes
A school-based program tests a body-positivity and dissonance-based approach to reduce body dissatisfaction and risk for eating disorders among 13- to 17-year-old athletes in Norway.
-
PRETA: a digital school program to prevent eating disorders in fifth- and sixth-grade students.
This trial will test a nine‑session online school program (PRETA) to see if it reduces eating-disorder risk and related factors in fifth- and sixth-grade students.
-
New treatment program for adolescents with eating disorders
This study is testing a new treatment program for teenagers with serious eating disorders to see if it helps them feel better and recover over about 16 to 20 weeks.
-
National Highly Specialized Care for Severe Self-Harm and Eating Disorders in Swedish Youth
This observational study tests how well NHV, a highly specialized care program, works for children and teens with severe self-harm or eating disorders by asking patients and their parents about their experiences and what changes they notice.
-
National Highly Specialized Care for adults with treatment-resistant self-harm and eating disorders (Substudy 1)
This study tests how people with severe, hard-to-turge self-harm or eating disorders in Sweden experience NHV care and whether the treatment helps with symptoms and daily functioning.
-
FlexED: A digital program to help young women see thoughts and feelings about their body in a friendlier way
This trial tests a smartphone-based, gamified ACT-inspired program called FlexED to help young women and girls at risk for eating disorders see how they think and feel about their bodies, and to see if it can be feasibly spread to more people.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.